Cover Image

miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive disease with limited therapeutic options. Here, we pursued a combinatorial therapeutic approach to enhance the activity of selinexor, the first-in-class XPO1 inhibitor, by miR-34a ectopic expression in human TNBC experimental models. Anti-prolife...

Full description

Saved in:

Bibliographic Details
Main Authors:	Silvia Martini (Author), Valentina Zuco (Author), Monica Tortoreto (Author), Stefano Percio (Author), Elisa Campi (Author), Rihan El Bezawy (Author), Valentina Doldi (Author), Yosef Landesman (Author), Marzia Pennati (Author), Nadia Zaffaroni (Author)
Format:	Book
Published:	MDPI AG, 2021-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia
by: Mariarita Spampinato, et al.
Published: (2024)

Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft
by: Valentina Zuco, et al.
Published: (2023)

Selinexor and COVID-19: The Neglected Warden
by: Gomaa Mostafa-Hedeab, et al.
Published: (2022)

US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma
by: Bassali J, et al.
Published: (2020)

Targeting survivin in leukemia
by: Bing Z. Carter, et al.
Published: (2011)

Targeting survivin in leukemia
by: Bing Z. Carter, et al.
Published: (2011)

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients
by: Svoboda Marek, et al.
Published: (2012)

US Budget Impact Model for Selinexor, Bortezomib, and Dexamethasone for the Treatment of Previously Treated Multiple Myeloma
by: Dolph M, et al.
Published: (2021)

Exosomes-Coated miR-34a Displays Potent Antitumor Activity in Pancreatic Cancer Both in vitro and in vivo
by: Zuo L, et al.
Published: (2020)

Serum survivin is decreased in women with preeclampsia
by: Onur Güralp, et al.
Published: (2021)

Survivin Clinical Features in Cervical Cancer
by: Miftakh Nur Rahman, et al.
Published: (2017)

Selinexor, a selective inhibitor of nuclear export, inhibits human neutrophil extracellular trap formation in vitro
by: Szilvia Baron, et al.
Published: (2022)

Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor
by: Joseph NS, et al.
Published: (2021)

Establishment and Verification of UPLC-MS/MS Technique for Pharmacokinetic Drug–Drug Interactions of Selinexor with Posaconazole in Rats
by: Zhou C, et al.
Published: (2021)

Phosphorylation Modulates Survivin Function in Behcet's Disease
by: Yasamin Pahlavan, et al.
Published: (2020)

Serum survivin as biomarker in retinoblstoma: Hope or hype?
by: Shilpa Khanna Arora, et al.
Published: (2022)

Prognostic and clinicopathological significance of survivin in gynecological cancer
by: Agapiti H. Chuwa, et al.
Published: (2024)

Dual Regulation of miR-34a and Notch Signaling in Triple-Negative Breast Cancer by Antibody/miRNA Nanocarriers
by: Danielle M. Valcourt, et al.
Published: (2020)

Safety and Efficacy Analysis of Selinexor-Based Treatment in Multiple Myeloma, a Meta-Analysis Based on Prospective Clinical Trials
by: Yali Tao, et al.
Published: (2021)

Selinexor and Other Selective Inhibitors of Nuclear Export (SINEs)-A Novel Approach to Target Hematologic Malignancies and Solid Tumors
by: Kajetan Karaszewski, et al.
Published: (2023)

Selinexor and the Selective Inhibition of Nuclear Export: A New Perspective on the Treatment of Sarcomas and Other Solid and Non-Solid Tumors
by: Antonella Lucia Marretta, et al.
Published: (2021)

Survivin is essential for thermogenic program and metabolic homeostasis in mice
by: Miriayi Alimujiang, et al.
Published: (2022)

Antitumoral-Embedded Biopolymeric Spheres for Implantable Devices
by: Valentina Grumezescu, et al.
Published: (2024)

Expression of survivin in oral potentially malignant disorders: An immunohistochemical study
by: Venkatraman R Rajanna, et al.
Published: (2020)

IS SURVIVIN LEVEL IDENTICAL BETWEEN ADENOMAS OF PROXIMAL AND DISTAL COLON?
by: Marian Adamkov, et al.
Published: (2022)

Expression and clinicopathological significance of antiapoptotis protein survivin in gallbladder cancer
by: Vishal Gupta, et al.
Published: (2016)

LncRNA AB209371 up-regulated Survivin gene by down-regulating miR-203 in ovarian carcinoma
by: Zi-Hui Zheng, et al.
Published: (2019)

Small-Molecule Intervention At The Dimerization Interface Of Survivin By Novel Rigidized Scaffolds
by: Ibrahim TM, et al.
Published: (2019)

Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
by: Isabel Blanco, et al.
Published: (2023)

A Gold Nanocage Probe Targeting Survivin for the Diagnosis of Pancreatic Cancer
by: Lina Song, et al.
Published: (2023)

Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer
by: Cai Xiaopeng, et al.
Published: (2012)

Dezocine, An Opioid Analgesic, Exerts Antitumor Effects in Triple-Negative Breast Cancer by Targeting Nicotinamide Phosphoribosyltransferase
by: Chenyang Xue, et al.
Published: (2021)

Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines
by: Paola Maria Bonaccorsi, et al.
Published: (2019)

Real-world experience with selinexor-containing chemotherapy-free or low-dose chemotherapy regimens for patients with relapsed/refractory acute myeloid leukemia and myeloid sarcoma
by: Xiwen Tong, et al.
Published: (2023)

Optimizing Antitumor Effect of Triple-Negative Breast Cancer via Rosmarinic Acid-β-Cyclodextrin Inclusion Complex
by: Yuan Li, et al.
Published: (2024)

The role of survivin in the pathogenesis of genital endometriosis, current application possibilities (literature review)
by: Elena V. Misharina, et al.
Published: (2020)

Effect of antisense oligodeoxynucleotide targeting survivin on growth of human gastric cancer cells
by: Lantao Xu
Published: (2013)

Survivin and Her2 Expressions in Different Grades of Urothelial Neoplasms of Urinary Bladder
by: Hedieh Moradi Tabriz, et al.
Published: (2020)

Sodium propionate improves rheumatoid arthritis by inhibiting survivin mediated proliferation of fibroblast like synoviocytes by promoting miR-140-5p
by: Sha Ma, et al.
Published: (2022)

Mir-34: A New Weapon Against Cancer?
by: Gabriella Misso, et al.
Published: (2014)